Page 41 - Read Online
P. 41

Balakrishnan et al. J Cancer Metastasis Treat 2022;8:27            Journal of Cancer
               DOI: 10.20517/2394-4722.2022.33
                                                                       Metastasis and Treatment




               Review                                                                        Open Access



               Role of myeloid cells in the tumor microenvironment


               Arpita Balakrishnan, Mohini Vig, Shweta Dubey
               Amity Institute of Virology and Immunology, Amity University Uttar Pradesh (AUUP), Noida 201303, India.
               Correspondence to: Dr. Shweta Dubey, Amity Institute of Virology & Immunology, Amity University Uttar Pradesh (AUUP),
               Noida 201303, India. E-mail: sdubey@amity.edu

               How to cite this article: Balakrishnan A, Vig M, Dubey S. Role of myeloid cells in the tumor microenvironment. J Cancer
               Metastasis Treat 2022;8:27. https://dx.doi.org/10.20517/2394-4722.2022.33

               Received: 6 Apr 2022  First Decision: 11 May 2022  Revised: 28 May 2022  Accepted: 4 Jul 2022  Published: 26 Jul 2022

               Academic Editor: Lucio Miele  Copy Editor: Fangling Lan  Production Editor: Fangling Lan

               Abstract
               The dynamic interplay between tumor cells and immune cells in the microenvironment plays a crucial role in
               determining disease severity and therapeutic outcome in cancer. Myeloid cells are the most abundantly available
               cell population in the tumor microenvironment. Myeloid cells have been shown to exist in diverse phenotypes and
               play both antitumoral and protumoral roles in cancer. Understanding the biology of myeloid cells can lay the
               foundation for the development of therapeutic strategies aimed at enhancing the antitumoral role of myeloid cells.
               This article presents an overview of the role of myeloid cells in tumor development and various mechanisms by
               which myeloid cells aid tumor progression. Existing drugs against cancer that utilize myeloid cells and the role of
               myeloid cells in drug resistance are also discussed.

               Keywords: Myeloid cells, tumor, cancer, tumor microenvironment, tumor-associated macrophages, dendritic cells,
               tumor-associated neutrophils, myeloid-derived suppressor cells



               INTRODUCTION
               Tumor progression is modulated by genetic and epigenetic changes in tumor cells. The mutual and dynamic
               crosstalk with the components of the tumor microenvironment (TME) also play a substantial role in tumor
                         [1]
               progression . As defined by the National Cancer Institute, “TME is a group of normal cells, molecules, and
               blood vessels that surround and aid in the growth of the tumor cell. Tumor development tends to shape the
               microenvironment, which in turn affects the way a tumor grows and spreads” . TME is comprised of
                                                                                     [2]
               proliferating tumor cells, tumor stroma, blood vessels, recruited immune cells, a variety of associated tissue






                           © The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing,
                           adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as
               long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
               indicate if changes were made.

                                                                                           www.jcmtjournal.com
   36   37   38   39   40   41   42   43   44   45   46